the Timing and Efficacy of Liver Treatment with Hepatitis B - Gastroenterology and Hepatology

More Info

---

When it comes to managing chronic Hepatitis B, especially for someone who has been a carrier for several years, understanding the timing and efficacy of treatment is crucial. Based on your situation, where you have been experiencing fluctuating liver enzyme levels (GOT and GPT) and recently noted an increase in liver inflammation, it is important to address both the timing of treatment initiation and the potential long-term implications of antiviral therapy.


Timing of Treatment
The decision to initiate antiviral therapy for Hepatitis B is typically guided by several factors, including liver enzyme levels, the presence of liver inflammation, and the degree of liver fibrosis or cirrhosis. According to current guidelines, treatment is generally recommended when:
1. Liver Enzymes are Elevated: A GPT level greater than twice the upper limit of normal (usually around 40 U/L) is often a threshold for considering treatment. In your case, with GPT levels fluctuating and showing recent increases, this could indicate active liver inflammation that warrants closer monitoring and possibly treatment.

2. Viral Load: The presence of high levels of Hepatitis B virus (HBV) in the blood (measured in copies/mL) can also influence the decision to start treatment. If your viral load is significant, it may be advisable to begin antiviral therapy even if liver enzymes are not extremely elevated.

3. Fibrosis Assessment: If there is evidence of significant liver fibrosis or cirrhosis, treatment is usually recommended regardless of enzyme levels. Regular monitoring through non-invasive tests like FibroScan can help assess the degree of fibrosis.


Efficacy of Treatment
Starting antiviral therapy like "肝安能" (likely referring to a nucleos(t)ide analogue) at the right time is essential for maximizing its efficacy. While it is true that some studies suggest that starting treatment when liver enzymes are elevated (such as GPT > 200) may be beneficial, initiating treatment earlier in the course of the disease can also prevent progression to more severe liver damage.

1. Antiviral Resistance: Concerns about antiviral resistance are valid, especially with long-term use of medications. However, the risk of developing resistance is generally lower with newer agents like tenofovir and entecavir compared to older therapies. Regular monitoring and adherence to the prescribed regimen can mitigate this risk.

2. Long-term Management: It is important to understand that Hepatitis B is a chronic condition that often requires long-term management. While some patients may achieve sustained viral suppression, others may experience flares of liver inflammation. Therefore, ongoing monitoring and possibly adjusting treatment based on liver function tests and viral load are necessary.


Seeking Specialized Care
Regarding your question about seeking treatment at a certified hospital like NTU Hospital, it is advisable to consult with a hepatologist or a specialist in liver diseases. They can provide a comprehensive evaluation of your condition and help determine the best course of action. If you have health insurance, you may be eligible for coverage for antiviral medications, depending on your specific circumstances and the hospital's policies.


Conclusion
In summary, the timing of initiating antiviral therapy for Hepatitis B is critical and should be based on liver enzyme levels, viral load, and liver fibrosis status. While starting treatment at elevated enzyme levels can be beneficial, it is also important to consider the long-term implications of therapy and the potential for antiviral resistance. Regular follow-ups with a liver specialist will ensure that you receive the most appropriate care tailored to your condition. Always discuss any concerns with your healthcare provider to make informed decisions about your treatment plan.